Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by aspergillus allergens.

INTRODUCTION Fifteen to sixty percent of cystic fibrosis patients harbor Aspergillus fumigatus (Af) in their airways (CF-AC) and some will develop allergic bronchopulmonary aspergillosis (CF-ABPA). Since basophils play a key role in allergy, we hypothesized that they would display alterations in CF-ABPA patients compared to CF-AC or patients without Af colonization (CF). METHODS Using flow cytometry, we measured CD203c, CD63 and CD123 levels on basophils from CF-ABPA (N=11), CF-AC (N=14), and CF (N=12) patients before and after ex vivo stimulation with Af allergens. RESULTS Baseline CD203c was increased in basophils from CF-ABPA compared to CF-AC and CF patients. Af extract and recombinant Aspf1 stimulated basophils from CF-ABPA patients to markedly upregulate CD203c, along with modest upregulation of CD63 and a CD123 downward trend. Plasma TARC/CCL17 at baseline and post-stimulation cell supernatant histamine levels were similar in the three groups. CONCLUSIONS In CF-ABPA, blood basophils are primed and hyperresponsive to Af allergen stimulation.

[1]  S. Huq.  Role of kinase suppressor of Ras-1 in Pseudomonas aeruginosa infections , 2011, Thorax.

[2]  M. Judson.  Allergic bronchopulmonary aspergillosis after infliximab therapy for sarcoidosis: a potential mechanism related to T-helper cytokine balance. , 2009, Chest.

[3]  P. Davis,et al.  Cystic fibrosis since 1938. , 2006, American journal of respiratory and critical care medicine.

[4]  U. Demkow,et al.  Basophil activation test based on the expression of CD203c in the diagnostics of cow milk allergy in children , 2010, European journal of medical research.

[5]  J. Latgé,et al.  Aspergillus fumigatus and Aspergillosis , 1999, Clinical Microbiology Reviews.

[6]  U. Frey,et al.  Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis , 2008, European Respiratory Journal.

[7]  P. Gilligan,et al.  Microbiology of airway disease in patients with cystic fibrosis , 1991, Clinical Microbiology Reviews.

[8]  K. Nadeau,et al.  Basophil CD203c Levels Are Increased at Baseline and Can Be Used to Monitor Omalizumab Treatment in Subjects with Nut Allergy , 2010, International Archives of Allergy and Immunology.

[9]  R. Girot,et al.  Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  M. Skov,et al.  Aspergillus Species and Other Molds in Respiratory Samples from Patients with Cystic Fibrosis: a Laboratory-Based Study with Focus on Aspergillus fumigatus Azole Resistance , 2011, Journal of Clinical Microbiology.

[11]  L. Delhaes,et al.  Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review. , 2009, Medical mycology.

[12]  S. Gallati,et al.  Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. , 2006, American journal of respiratory and critical care medicine.

[13]  R. Tirouvanziam.  Neutrophilic inflammation as a major determinant in the progression of cystic fibrosis. , 2006, Drug news & perspectives.

[14]  R. Patterson,et al.  Hyperreactivity of mediator-releasing cells from patients with allergic bronchopulmonary aspergillosis as evidenced by basophil histamine release. , 1983, The Journal of allergy and clinical immunology.

[15]  H. Fricker-Hidalgo,et al.  Recombinant Allergens Combined with Biological Markers in the Diagnosis of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Patients , 2010, Clinical and Vaccine Immunology.

[16]  R. Moss.  Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis , 2010, Current opinion in pulmonary medicine.

[17]  P. Valent,et al.  Individual Hymenoptera Venom Compounds Induce Upregulation of the Basophil Activation Marker Ectonucleotide Pyrophosphatase/Phosphodiesterase 3 (CD203c) in Sensitized Patients , 2002, International Archives of Allergy and Immunology.

[18]  A. Bush,et al.  Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis , 2011, Thorax.

[19]  R. Crameri,et al.  Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. , 1998, International immunology.

[20]  J. Kolls,et al.  Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. , 2009, Medical mycology.

[21]  L. Delhaes,et al.  Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: State of the art and further challenges. , 2010, Medical mycology.

[22]  David W. Denning,et al.  Erratum: Allergic bronchopulmonary aspergillosis in cystic fibrosis - State of the art: Cystic Fibrosis Foundation Consensus Conference (Clinical Infectious Diseases (2003) 37:Suppl. 3 (S225-64)) , 2004 .

[23]  J. Fox,et al.  Brief Definitive Report , 2022 .

[24]  J. Elborn,et al.  Fungal infections in patients with cystic fibrosis , 2007 .

[25]  P. Vichyanond.  Omalizumab in allergic diseases, a recent review. , 2011, Asian Pacific journal of allergy and immunology.

[26]  K. Nadeau,et al.  Modulation of mTOR Effector Phosphoproteins in Blood Basophils from Allergic Patients , 2012, Journal of Clinical Immunology.

[27]  S. Dreskin,et al.  Chronic urticaria sera increase basophil CD203c expression. , 2006, The Journal of allergy and clinical immunology.

[28]  A. Bush,et al.  Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis. , 1994, Thorax.

[29]  E. Morita,et al.  Antigen-induced expression of CD203c on basophils predicts IgE-mediated wheat allergy. , 2009, Allergology international : official journal of the Japanese Society of Allergology.

[30]  L. Kanz,et al.  The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3. , 2001, Blood.

[31]  D. MacGlashan.  Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[32]  A. White,et al.  Mediators of histamine release from human platelets, lymphocytes, and granulocytes. , 1971, The Journal of clinical investigation.

[33]  N. Abuaf,et al.  Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. , 1999, The Journal of allergy and clinical immunology.

[34]  S. Aaron,et al.  The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. , 2010, Chest.

[35]  J. Oak,et al.  Allergic bronchopulmonary aspergillosis. , 1996, Journal of postgraduate medicine.

[36]  Michael Light,et al.  Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  M. Bonten,et al.  Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[38]  E. Kerem,et al.  Aspergillus bronchitis in cystic fibrosis. , 2006, Chest.